Japan-based Sawai Pharmaceutical has agreed to buy the generic drugs business of Upsher-Smith Laboratories for nearly $1.1 billion.
Harvard Stem Cells Institute, a network of stem cell scientists, has entered into a collaboration agreement with stem cells manufacturer Cellular Dynamics International.
Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.
US-based law firm Honigman Miller Schwartz and Cohn has hired Simeon Papacostas as a partner in the firm’s IP department.
Medical technology company NeuroGrafix and Toshiba Medical have entered into a settlement agreement following a patent dispute over MRI imaging technology.
Shire Viropharma has filed a complaint against CSL Behring, a developer of rare disease therapies, for patent infringement.
The University of California, Berkeley and the University of Vienna have appealed against the Patent Trial and Appeal Board's decision in the dispute over CRISPR technology.
Takeda will sell a number of its off-patent drugs, used for treatment of diabetes, hypertension and peptic ulcers, to Teva Takeda Yakuhin for ¥28.5 billion.
The US International Trade Commission has launched an investigation into intravascular administration sets, based on a complaint filed by medical device companies Curlin Medicals, Moog and Zevex.
Brazil’s President Michel Temer has revealed measures aimed at improving the IP system in the country.